There are 2867 resources available
117P - BiomeOne: Multi-centric validation of a novel microbiome-based biomarker to predict response to cancer immunotherapy
Presenter: Irina Robinson
Session: Poster session 01
118P - Predictive role of neutrophil lymphocyte ratio (NLR) in metastatic solid tumour patients receiving immune checkpoint inhibitors (ICI)
Presenter: Anuradha Mehta
Session: Poster session 01
119P - Characterisation of distinct subgroups of BRCA1-like triple-negative breast cancers with multiomics data analysis
Presenter: Terry Wing Sheung Chan
Session: Poster session 01
120P - The predictive value of LATS1 mutation for immune checkpoint inhibitors therapy in bladder cancer
Presenter: junjun Li
Session: Poster session 01
121P - Spectrum of druggable gene fusions in microsatellite-unstable colorectal tumors
Presenter: Evgeny Imyanitov
Session: Poster session 01
122P - Can circulating PD-1, PD-L1, pan-BTN3As, BTN3A1, BTN2A1 and BTLA levels enhance prognostic power of serum CA125 in patients with advanced high-grade serous ovarian cancer?
Presenter: Lidia Rita Corsini
Session: Poster session 01
123P - Correlation between MSI, TMB and BLM gene mutation in solid tumors
Presenter: yu jinhai
Session: Poster session 01
124P - Durvalumab in advanced, pre-treated microsatellite instability-high solid tumors: Results of a tumor-agnostic DRUP trial cohort
Presenter: Birgit Geurts
Session: Poster session 01
125P - Assessing the accuracy of multiple prognostic scores for immune checkpoint inhibitors (ICI) in patients with advanced solid tumors
Presenter: Javier Garcia-Corbacho
Session: Poster session 01
126P - The HLA I composite score and VHIO immune gene-expression signature (VIGex) as selection tools to explore the tumor microenvironment (TME) in patients (pts) treated with immunotherapy (IT)
Presenter: Omar Saavedra Santa Gadea
Session: Poster session 01